MedTrace Logo

Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel

NCT02571283 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2017-04-06

No results posted yet for this study

Summary

A prospective, randomized control study will be conducted to compare postoperative pain control in a series of patients treated with either:

1. a local cocktail.
2. a local cocktail plus Exparel.
3. marcaine plus Exparel prior to wound closure following knee arthroplasty.

Conditions

  • Total Knee Arthroplasty
  • Pain Management

Interventions

DRUG

Cocktail

Administered as a single dose injection.

DRUG

Exparel

Administered 20 minutes+ before additional medications.

DRUG

Marcaine

Administered 20 minutes or more after Exparel is administered.

Sponsors & Collaborators

  • Arthroplasty Foundation, Inc.

    collaborator OTHER

  • University of Louisville

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-05-31
Completion
2016-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02571283 on ClinicalTrials.gov